Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 177.4B | 165.6B | 180.6B | 169.6B |
Cost of revenue | 132.8B | 124.3B | 136.2B | 127.3B |
Gross profit | 44.6B | 41.3B | 44.4B | 42.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | 36.5B | 35.5B |
Other operating expenses | 37.3B | 34.2B | 36.5B | 35.5B |
Operating income | 7.3B | 7.1B | 7.9B | 6.7B |
Non operating interest income | ||||
Income | 94M | 93M | 115M | 140M |
Expense | 769M | 637M | 717M | 618M |
Other income expense | 2.7B | -597M | -294M | -132M |
Pretax income | 9.3B | 6.0B | 7.0B | 6.1B |
Tax provision | 2.2B | 1.4B | 1.5B | 1.4B |
Net income | 7.2B | 4.6B | 5.4B | 4.7B |
Basic EPS | 0.9 | 0.6 | 0.7 | 0.6 |
Diluted EPS | 0.9 | 0.6 | 0.7 | 0.6 |
Basic average shares | 8.0B | 8.0B | 8.0B | 8.0B |
Diluted average shares | 8.0B | 8.1B | 8.1B | 8.1B |
EBITDA | 13.6B | 10B | 11.1B | 10.0B |
Net income from continuing op. | 7.2B | 4.6B | 5.4B | 4.7B |
Minority interests | -125M | -152M | -171M | -137M |
Preferred stock dividends | — | — | — | — |